BAYN Bayer Aktiengesellschaft
43.89EUR-2.34%Mkt Cap: 46.94B $P/E: —1d ago
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates thro…
Industry Peers
Drug Manufacturers - GeneralKey Statistics
Company
Market Cap46.94B USD
Enterprise Value84.37B USD
Revenue (TTM)49.32B USD
Gross Profit29.11B USD
Net Income (TTM)-3.93B USD
Revenue/Share46.19 EUR
Last Price43.89 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees87.8K
CountryDE
SectorHealthcare
IndustryDrug Manufacturers - General
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)9.31
PEG4.65
EV/EBITDA7.66
EV/Revenue1.71
P/S0.97
P/B1.49
EPS (TTM)-1.76
EPS (Forward)4.83
52W Range
26.0264% of range53.92
52W High53.92 EUR
52W Low26.02 EUR
Profitability
Gross Margin58.76%
Oper. Margin9.19%
EBITDA Margin22.33%
Profit Margin-7.94%
ROE-13.95%
ROA-3.46%
Growth
Revenue Growth1.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF6.45B USD
CapEx (TTM)2.70B USD
FCF Margin14.46%
FCF Yield15.20%
Net Debt36.25B USD
Net Debt/EBITDA3.29
Balance Sheet
Debt/Equity1.40
Current Ratio1.04
Quick Ratio0.67
Book Value/Sh30.11 EUR
Cash/Share5.17 EUR
Dividends
Fwd Div Rate0.11 EUR
Trail. Div Rate0.11 EUR
Div. Yield0.24%
5Y Avg Yield0.67%
Payout Ratio162.16%
Ex-Div DateApr 27, 2026
Pay Date—
Analyst Consensus
Rating1.9 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)58.22 EUR
Upside (mean)+32.7%
Target Range46.00 EUR – 70.00 EUR
46.00+32.7% to mean70.00
# Analysts18
Ownership
Shares Out.982.42M
Float982.42M
Insiders0.01%
Institutions61.47%
Technical
SMA 5048.59 (-9.7%)
SMA 20043.03 (+2.0%)
Beta0.83
S&P 52W Chg14.58%
Avg Vol (30d)2.15M
Avg Vol (10d)2.30M
Technical Indicators
RSI (14)29.3
MACD-0.7040
MACD Signal-0.0919
MACD Hist.-0.6121
BB Upper51.90 EUR
BB Middle48.45 EUR
BB Lower44.99 EUR
BB Width14.26%
ATR (14)1.380 EUR
Vol Ratio (20d)1.00x